Hopp til hovedinnhold

N06A - Antidepressiver

Sist oppdatert: Sist revidert:
Sist revidert av:


  • Legemiddelkapittelet bygger på informasjon fra Felleskatalogen, Norsk Legemiddelhåndbok og diverse farmakologiske oppslagsverk
  1. Hansen RA, Gartlehner G, Lohr KN, Gaynes BN, Carey TS. Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder. Ann Intern Med 2005; 143: 415-26. Annals of Internal Medicine  
  2. Spigset O, Mårtensson B. Drug treatment of depression. BMJ 1999; 318: 1188-91. British Medical Journal  
  3. Thase ME, Greenhouse JB, Frank C et al. Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations. Arch Gen Psychiatry 1997; 54: 1009-15. PubMed  
  4. National Institute for Clinical Excellence. Depression: management of depression in primary and secondary care. Clinical Guideline 23. London: NICE, 2004. www.nice.org.uk/pdf/CG023quickrefguide.pdf (accessed 6 Jan 2005).
  5. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 2008; 5: e45. PubMed  
  6. Taylor MJ, Freemantle N, Geddes JR, Bhagwagar Z. Early onset of selective serotonin reuptake inhibitor antidepressant action: Systematic review and meta-analysis. Arch Gen Psychiatry 2006; 63: 1217-23. PubMed  
  7. Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 2009; 373: 746-58. PubMed  
  8. Gunnell D, Ashby D. Antidepressants and suicide: what is the balance of benefit and harm. BMJ 2004; 329: 34-8. PubMed  
  9. Castberg I. Seponeringssyndrom etter behandling med antidepressiver. Tidsskr Nor Lægeforen 2004; 124: 2493-4. PubMed  
  10. Frost J, Sandvik P, Spigset O. Seksuelle bivirkninger av antidepressive legemidler. Tidsskr Nor Legeforen 2010; 130: 1930-1. Tidsskrift for Den norske legeforening  
  11. Khan A, Khan S, Kolts R, Brown WA. Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports. Am J Psychiatry 2003; 160: 790-2. PubMed  
  12. Paton C, Ferrier IN. SSRIs and gastrointestinal bleeding. BMJ 2005; 331: 529-30. PubMed  
  13. De Abajo FJ, Rodriguez LA, Montero D. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. BMJ 1999; 319: 1106-9. PubMed  
  14. Dalton SO, Johansen C, Mellemkjær L, Nørgård B, Sørensen HT, Olsen JH. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med 2003; 163: 59-64. PubMed  
  15. Renoux C, Vahey S, Dell'Aniello S, Boivin JF. Association of selective serotonin reuptake inhibitors with the risk for spontaneous intracranial hemorrhage. JAMA Neurol 2016. pmid:27918771 PubMed  
  16. Venflaksine: more dangerous than most "selective" serotonergic antidepressants. Prescrire INtr 2016; 25: 96-9. pmid:27186622 PubMed  
  17. Castro VM, Clements CC, Murphy SN, et al. QT interval and antidepressant use: a cross sectional study of electronic health records. BMJ 2013; 346: f288. BMJ (DOI)  
  18. Coupland C et al. Antidepressant use and risk of cardiovascular outcomes in people aged 20 to 64: Cohort study using primary care database. BMJ 2016; 352: i1350. doi:10.1136/bmj.i1350 DOI  
  19. Eyding D, Lelgemann M, Grouven U. Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials . BMJ 2010; 341: c4737. BMJ (DOI)  
  20. Reis M, Källén B. Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychol Med 2010; 5: 1-11. PubMed  
  21. Berle JØ. Behandling av svangerskapsrelatert psykisk sykdom. Tidsskr Nor Lægeforen 2003; 123: 2037-40. PubMed  
  22. Malm H, Sourander A, Gissler M, et al. Pregnancy Complications Following Prenatal Exposure to SSRIs or Maternal Psychiatric Disorders: Results From Population-Based National Register Data. Am J Psych 2015. doi:10.1176/appi.ajp.2015.14121575 DOI  
  23. Furu K, Kieler H, Haglund B, et al. Selective serotonin reuptake inhibitors and venflaksine in early pregnancy and risk of birth defects: population based cohort study and sibling design. BMJ 2015. doi:http://dx.doi.org/10.1136/bmj.h1798
  24. Reefhuis J, Devine O, Friedman JM, et al. Specific SSRIs and birth defects: bayesian analysis to interpret new data in the context of previous reports. BMJ 2015; 351: h3190. doi:10.1136/bmj.h3190 DOI  
  25. Kieler H, Artama M, Engeland A, et al. Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries. BMJ 2012; 344: d8012. BMJ (DOI)  
  26. Huybrechts KF, Bateman BT, Palmsten K, et al. Antidepressant use late in pregnancy and risk of persistent hypertension of the newborn. JAMA 2015; 313: 2142-51. doi:10.1001/jama.2015.5605 DOI  
  27. Lund N, Pedersen LH, Henriksen TB. Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes. Arch Pediatr Adolesc Med;2009:163, 949-54.
  28. Stephansson O, Kieler H, Haglund B, et al. Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality. JAMA 2013 Jan 2; 309(1): 48-54. PubMed  
  29. Marroun HE, Jaddoe VWV, Hudziak JJ, et al. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes. Arch Gen Psychiatry 2012; : doi:10.1001/archgenpsychiatry.2011.2333. DOI  
  30. Rai D, Lee BK, Dalman C, et al. Parental depression, maternal antidperessant us during pregnancy, and risk of atism spectrum disorders: population based case-control study. BMJ 2014; 346: f2059. BMJ (DOI)  
  31. Handal M, Skurtveit S, Furu K, Hernandez-Diaz S, Skovlund E, Nystad W, Selmer R. Motor development in children prenatally exposed to selective serotonin reuptake inhibitors: a large population-based pregnancy cohort study. BJOG. 2015, Sep 15. doi: 10.1111/1471-0528.13582. DOI  
  32. Lunde I, Langaas HC. Vortioksetin og graviditet. RELIS 2017. relis.no  
  • Olav Spigset, overlege, professor dr. med., Avdeling for klinisk farmakologi, St. Olavs Hospital
  • Ingard Løge, spesialist i allmennmedisin, Edda legesenter. Universitetslektor, Institutt for samfunnsmedisinske fag, Norges teknisk-naturvitenskapelige universitet, Trondheim